Together, our results indicated that YBX1 is an important promoter of LSCC progression. And miR-382-5p/YBX1/RAS/MAPK signaling pathway can be perceived as a promising target in the treatment of LSCC.
Keyphrases
- signaling pathway
- pi k akt
- squamous cell carcinoma
- induced apoptosis
- epithelial mesenchymal transition
- wild type
- oxidative stress
- depressive symptoms
- social support
- dna methylation
- mental health
- physical activity
- transcription factor
- cancer therapy
- combination therapy
- cell proliferation
- radiation therapy
- lymph node metastasis
- smoking cessation